• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
Wednesday, February 8, 2023
Galveston County News Online
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Popular
No Result
View All Result
No Result
View All Result
Home Business

People In The News: New Appointments At Singular Genomics, Molecular Stethoscope, Veracyte, More – GenomeWeb

Share on FacebookShare on Twitter

Singular Genomics: Elaine Mardis

Singular Genomics has added Elaine Mardis to its board of directors. Since 2016, Mardis has served as co-executive director of the Institute of Genomic Medicine at Nationwide Children’s Hospital, and holds the Steve and Cindy Rasmussen endowed chair in genomic medicine. She is also a professor of pediatrics at the Ohio State University College of Medicine. Mardis also serves on the supervisory board, science and technology committee, and compensation and human resources committee at Qiagen. She is currently deputy editor for the peer-reviewed journal Disease Models and Mechanisms, co-editor-in-chief of Cancer Research Communications, and editor-in-chief of Molecular Case Studies. Previously, Mardis was a member of the faculty of the Washington University School of Medicine for 22 years. She holds a PhD in chemistry and biochemistry, and a BS in zoology from the University of Oklahoma.


Molecular Stethoscope: Gajus Worthington

Molecular Stethoscope has appointed Gajus Worthington as executive chairman of its board of directors. Worthington has been chief operating officer of the Chan Zuckerberg Biohub since May of 2017, where he has worked with leadership to set strategy, build, and oversee much of the organization. Prior to that, he served as CEO of Fluidigm, where, during a 17-year tenure, he led the development and commercialization of that company’s microfluidics technology, with applications in single-cell genomics, agriculture, and diagnostic testing. Worthington holds a bachelor’s degree in physics and a master’s degree in electrical engineering from Stanford University. He is an elected fellow of the American Institute for Medical and Biological Engineering.


Veracyte: Tina Nova, Stephane Debono, Giulia Kennedy

Veracyte has appointed Tina Nova as president of its US CLIA business, Stephane Debono as general manager of the company’s in vitro diagnostics and EMEA organizations, and Giulia Kennedy as its global chief scientific officer and chief medical officer.

In her role, Nova will lead market development, product marketing, payer reimbursement, sales, and operations for all diagnostic tests that are performed in the company’s US laboratories. Nova served most recently as Veracyte’s general manager of thyroid and urologic cancers. She was CEO of Decipher Biosciences prior to Veracyte’s March 2021 acquisition of that company.

Debono will oversee the development, manufacturing, market access, sales, and marketing of the company’s IVD tests on the nCounter Analysis System to laboratories in global markets. He previously served as Veracyte’s general manager for the immunoscore assay and international diagnostics operations. He was also deputy CEO of HalioDx prior to its acquisition by Veracyte in August 2021.

In her expanded role, Kennedy will oversee a worldwide team of research and development, medical affairs, data science, and clinical affairs professionals. She joined Veracyte in 2008, serving most recently as chief scientific officer and chief medical officer.


Myriad Genetics: Jerry Lanchbury, Dale Muzzey, Kirsten Timms

Myriad Genetics this week announced the retirement of Jerry Lanchbury as its CSO after nearly two decades at the company. Since he joined Myriad in 2002, he has led efforts to gain regulatory approval for the company’s companion diagnostics, BRACAnalysis CDx and myChoice CDx; improve hereditary cancer risk score determinations by developing a polygenic breast cancer risk score for all ancestries; and develop Myriad’s Prolaris Prostate Cancer Test. Lanchbury will continue to advise Myriad through the end of Q1 2022. The company is searching nationally for a permanent CSO.

In the interim, Dale Muzzey, formerly the VP of bioinformatics, who Myriad recently promoted to senior VP for R&D, will serve as CSO. Myriad also announced that Kirsten Timms, former VP of biomarker discovery, is now a senior VP, and will work on expanding the capabilities of MyChoice CDx in her new role.


For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

Galveston County News Online

© 2021 Galveston County News Online

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer

Follow Us

No Result
View All Result
  • Home
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Galveston County News Online

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT